###begin article-title 0
###xml 63 71 <span type="species:ncbi:9606">Patients</span>
The Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Patients with Isolated Coronary Artery Ectasia
###end article-title 0
###begin p 1
Recommended by Charles Larry Campbell
###end p 1
###begin p 2
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background/Aim</italic>
###xml 126 131 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 294 299 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 326 333 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 364 369 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 564 569 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 662 669 644 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 732 737 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 854 855 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 901 902 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 920 930 890 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion</italic>
###xml 969 974 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1284 1289 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
###xml 936 944 <span type="species:ncbi:9606">patients</span>
Background/Aim. Coronary artery ectasia (CAE) is considered as a variant of atherosclerosis. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) are among the sensitive markers of systemic inflammation. The aim of this study was to evaluate the plasma levels of the cytokines; TNF-alpha and IL-6 in CAE patients. Methods. Plasma concentrations of TNF-alpha and IL-6 were measured in 36 patients with CAE (28 males, mean age: 58.2 +/- 12 years), and results were compared with age and sex-matched controls (n = 32) without coronary artery ectasia. TNF-alpha and IL-6 concentrations in blood were assesed by enzyme-linked immunosorbent assay (ELISA). Results. Baseline characteristics of the two groups were similar. TNF-alpha and IL-6 levels were significantly higher in CAE group than controls (15.6 +/- 11.2 pg/mL versus 7.8 +/- 3.7 pg/mL, P < .001, and 17.2 +/- 12.6 versus 7.6 +/- 2.1 P < .0001, resp.). Conclusion. CAE patients showed increases in TNF-alpha and IL-6 levels compared to the controls. This study provides evidence for alterations in the proinflamatory cytokines which suggest the involvement of the immune system in the pathophysiology of CAE. Further placebo-controlled studies are needed to evaluate the clinical significance of this increase in TNF-alpha and IL-6 levels.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">4</xref>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">5</xref>
Coronary artery ectasia (CAE) has been defined as localized or diffuse dilation of the coronary arteries exceeding the 1.5 fold of normal adjacent segment in coronary angiography [1, 2]. CAE is a rare finding among coronary artery anomalies and considered to be of either congenital or acquired origin [2, 3]. Prevalence of CAE appears to rise in recent years [4]. It is estimated that 50% of CAE is related to atherosclerosis, whereas 20%-30% of cases may be due to congenital anomalies [3, 5].
###end p 4
###begin p 5
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">5</xref>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">7</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 334 339 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 426 427 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">8</xref>
###xml 429 430 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">9</xref>
###xml 483 488 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 567 569 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">10</xref>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
Atherosclerosis is increasingly thought to be a chronic inflammatory disease [5-7]. Although it has been suggested that ectasia is commonly a variant of atherosclerosis, it is not known clearly why some patients with obstructive coronary artery disease (CAD) develop CAE, whereas others do not [1-3]. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) are significantly associated with coronary atherosclerosis [8, 9]. Although the increase in the plasma levels of TNF-alpha and IL-6 in obstructive CAD is well known, limited data are available in CAE [10].
###end p 5
###begin p 6
###xml 76 81 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
In this study, we aimed to evaluate the plasma levels of the cytokines; TNF-alpha and IL-6 in CAE patients.
###end p 6
###begin title 7
2. Method
###end title 7
###begin title 8
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
2.1. Patients
###end title 8
###begin p 9
###xml 128 136 <span type="species:ncbi:9606">patients</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
###xml 649 661 <span type="species:ncbi:9606">participants</span>
The study was designed as a case-control prospective study. The study population was selected from a series of 1820 consecutive patients who underwent coronary angiography in our hospital between January 2008 and September 2008 due to the presence of chest pain or positive or equivocal results of noninvasive screening tests for myocardial ischemia. Out of the 1820 patients, 36 consecutive patients who had angiographically normal coronary arteries with CAE (group I, 28 male, mean age: 58.2 +/- 12 years) and accepted to participate to our study after giving informed consent were identified and compared with age, and sex-matched 32 consecutive participants with angiographically show normal coronary arteries without CAE (group II, 25 male, mean age: 57.2 +/- 10 years). No significant difference was present between the two groups regarding the use of acetylsalicylic acid, beta blockers, nitrates, calcium-channel blockers, and statins.
###end p 9
###begin p 10
###xml 74 86 <span type="species:ncbi:9606">participants</span>
Written informed consent was obtained prior to enrollment from all of the participants. The study protocol was approved by the institutional ethics committee, and the study was conducted in accordance with the Decleration of Helsinki and Good Clinical practice (GCP)/International Conference on Harmonization (ICH) guidelines.
###end p 10
###begin p 11
Subjects were excluded if they had evidence of traumatic injury, acute coronary syndrome history, obstructive CAD, left ventricular dysfunction, left ventricular hypertrophy, cardiomyopathies, congenital heart disease, valvular heart disease, any abnormality in thyroid function test, arrhythmias, clinically unstable medical illness such as hepatic or renal impairment; a history of seizure, head trauma, or stroke, active infection, allergy, active inflammation, collagen vascular disease, cancer, and any other primary disease interfering with immune functions.
###end p 11
###begin title 12
2.2. Coronary Angiograms and Immunoassay
###end title 12
###begin p 13
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
In all patients, coronary angiography was performed using the Philips Angioscop X-ray (Integris BH 5000, Philips Medical Systems, Best, The Netherlands) using standard Judkins technique. Two experienced cardiologists, unaware of the patients clinical characteristics and biochemical results, reviewed all of the angiographic images. We used iohexol (Omnipaque, Nycomed Ireland, Cork, Ireland) as contrast agent during coronary angiography in the study patients.
###end p 13
###begin p 14
A coronary diameter index was defined for each segment as the coronary diameter divided by the body surface area (BSA). A coronary segment with a diameter index >/=1.5 fold of the control group was defined as ectatic. When there was no identifiable adjacent normal segment, the mean diameter of the corresponding coronary segment in the control group served as normal values.
###end p 14
###begin p 15
Blood samples of all individuals were taken 24 hours after coronary angiography from an antecubital vein. Blood samples were centrifuged immediately at 250 g for 10 minutes and stored at +4degreesC until assay. Triglyceride, total cholesterol, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein cholesterol concentrations were measured by automated chemistry analyzer (Aeroset, Abbott, Ill, USA) by using commercially available kits.
###end p 15
###begin p 16
###xml 304 309 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 527 532 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Ten mL of heparinized venous blood were collected with the plastic tubes from subjects at 08.00 a.m. Blood samples were santrifuged at 3000 rpm (rotor diameter: 16 cm) and preserved at -80degreesC. Analyses were performed by the immunologists, who were blinded to the condition of the samples. IL-6, TNF-alpha enzyme-linked immunosorbent assay (ELISA) kits were purchased by Biosource International Inc. (Camarillo, Calif, USA) and used according to the recommendations of the manufacturer. The minimum detectable doses of TNF-alpha and IL-6 are 1.1 pg/mL, 2.2 pg/mL, respectively. There was no cross-reactivity with other cytokines. All samples were assayed in duplicate.
###end p 16
###begin title 17
2.3. Statistical Analysis
###end title 17
###begin p 18
###xml 284 285 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 285 286 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 306 307 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 365 370 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 504 505 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical analysis was performed by using SPSS for windows 11.0 (Chicago, Ill, USA). Continuous variables were expressed as mean +/- SD, and categorical variables were expressed as percentage. Comparison of categorical and continuous variables between groups was performed by using x2 test and Student's t-test or Mann-Whitney U-test. The correlation between TNF-alpha and IL-6 levels and the number of ectasic vessels was assessed by the Pearson correlation, or the Spearman tests were appropriate. A P-value of <.05 was considered statistically significant. Shapiro Wilks test was used for the assessment of the distribution of continuous variables. All tests performed were two tailed.
###end p 18
###begin title 19
3. Results
###end title 19
###begin p 20
Reproducibility was estimated by analyzing all recordings on 2 separate occasions (intraobserver variability); to assess interobserver variability, investigators were blinded. Intraobserver and interobserver coefficients of variation averaged 5%.
###end p 20
###begin p 21
###xml 97 104 97 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 111 116 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 233 234 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 280 281 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 299 306 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 358 363 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 412 413 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 427 428 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 445 446 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Baseline demographic, clinical, and angiographic characteristics of the two groups were similar (Table 1). TNF-alpha and IL-6 levels were significantly higher in CAE group than controls (15.6 +/- 11.2 pg/mL versus 7.8 +/- 3.7 pg/mL, P < .001, and 17.2 +/- 12.6 versus 7.6 +/- 2.1 P < .0001, resp.) (Table 2). Besides no correlation was found between the TNF-alpha, IL-6 levels and the number of ectatic vessels (r = 0.012, and r = 0.138, resp., P > .05).
###end p 21
###begin title 22
4. Discussion
###end title 22
###begin p 23
###xml 47 55 <span type="species:ncbi:9606">patients</span>
The main finding of the present study was that patients with isolated CAE had significantly higher TNF-alfa and IL-6 levels compared to control subjects with angiographically normal coronary arteries.
###end p 23
###begin p 24
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">11</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">12</xref>
###xml 937 939 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">13</xref>
###xml 672 680 <span type="species:ncbi:9606">patients</span>
CAE is a well-recognized angiographic finding of abnormal coronary dilatation, and detected in 0.3%-5.3% of consecutive angiographic studies [11]. The gold standard for diagnosis of this type of ectasia is coronary angiography, which provides information about the possible size, sample, location, and number of ectasias. In fact, CAE is traditionally considered as a variant of coronary atherosclerosis. Clinically, it predisposes to adverse coronary events like vasospasm, thrombosis, and dissection [1]. In some studies, coronary aneurysms have also been strongly associated with an increased risk myocardial infarction [12]. Angina pectoris is a frequent complaint of patients with isolated CAE. Although many etiologies of CAE have been reported, the common coexistence with CAD has raised the idea that CAE may be a variant of CAD. Individual case reports have shown that isolated CAE may be a cause of silent myocardial ischemia [13].
###end p 24
###begin p 25
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">10</xref>
###xml 294 299 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
In this study, we found significantly higher levels of IL-6 in CAE patients when compared to control subjects with normal coronary arteries. Tokgozoglu et al. found similar results with our findings [10]. We suggest that this inflammatory state in the CAE patiens is responsible for higher TNF-alpha and IL-6 levels in CAE.
###end p 25
###begin p 26
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">14</xref>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
A recently published investigation reported that coronary flow reserve is significantly reduced in patients with CAE and put forward that microvascular dysfunction may be the underlying cause of exercise-induced myocardial ischemia [14].
###end p 26
###begin p 27
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">15</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">16</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">17</xref>
Inflammation is a protect mechanism of the body against infectious agents and injury. There is now a well-known common aggreement that atherosclerosis is an inflammatory disorder of the vessels. Although cause and pathways of atherosclerotic process are probably multiple and different in various clinical settings, the data showed that an inflammatory process was involved in all stages of atherosclerosis [15] including coronary spasm, delayed coronary flow, coronary microvessel dysfunction, silent myocardial ischemia, and restenotic process [16, 17]. As a results of these data, the idea of chronic inflammation as one of the key factors involved in atherosclerosis has come out and broaden into a new area of atherosclerotic diseases.
###end p 27
###begin p 28
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">18</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">10</xref>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
###xml 596 604 <span type="species:ncbi:9606">patients</span>
A few recent data have also emphasized that CAE is associated with systemic inflammatory response exposed by inreased inflammatory cytokines and C-reactive protein (CRP). Recently, a study indicated a cytokine-induced tissue inflammation in the pathogenesis of abdominal aortic aneurysms, and it has been documented that circulating IL-6 levels increase in these patients [18]. Tokgozoglu et al. [10] studied with CAE, and found that serum IL-6 levels were significantly higher in patients with CAE compared to controls. Our results confirmed these results. We found higher levels of IL-6 in CAE patients.
###end p 28
###begin p 29
###xml 17 19 17 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">19</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">20</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">21</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">22</xref>
###xml 125 133 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
###xml 622 630 <span type="species:ncbi:9606">patients</span>
###xml 808 816 <span type="species:ncbi:9606">patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
###xml 1064 1072 <span type="species:ncbi:9606">patients</span>
###xml 1195 1203 <span type="species:ncbi:9606">patients</span>
Yildirim et al. [19] studied the CAE and found that mean fluorescence intensity of CD45 and CD11b on the monocyte surface of patients with CAE was significantly higher when compared to controls. They speculated that increased levels of cellular adhesion molecules in patients with CAE may be an indicator of endothelial activation and inflammation and are likely to be in the causal pathway leading to coronary artery ectasia. Turhan et al. [20] demonstrated that the levels of CRP, a specific marker of chronic inflammation, were significantly higher in patients with isolated CAE. A recently published study showed that patients with isolated CAE have raised levels of plasma soluble intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin in comparison with patients with obstructive CAD without CAE and subjects with normal coronary arteries [21]. In addition, Turhan et al. evaluated CRP levels as a specific marker of inflammation in patients with CAE. They showed that increased levels of CRP were detected in patients with isolated CAE [22]. All these data indicate the presence of a chronic inflammation in the coronary circulation of the patients with CAE. Accordingly, CAE has been suggested to be a destructive inflammatory lesion of the vascular wall.
###end p 29
###begin p 30
Briefly, the approving of the importance of inflammation in atherosclerosis has both theoretical and practical clinical implications. The data have demonstrated that CAE is associated with inflammatory response exposed by increased inflammatory cytokines. Such studies may clarify the pathogenesis of CAE and direct towards new therapeutic applications.
###end p 30
###begin title 31
5. Conclusion
###end title 31
###begin p 32
###xml 33 38 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 160 165 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
In conclusion, we found that TNF-alpha and IL-6 levels were significantly higher in CAE patients than subjects with normal coronary arteries. We think that TNF-alpha and IL-6 measurements may be a good prognostic value in CAE patients as in stenotic ones, suggesting that vascular wall inflammation may play a role in the pathogenesis of CAE. Further placebo-controlled studies are needed to evaluate the clinical significance of increases in these markers.
###end p 32
###begin article-title 33
Aneurysmal coronary artery disease
###end article-title 33
###begin article-title 34
Coronary artery aneurysm
###end article-title 34
###begin article-title 35
Coronary artery ectasia-a variant of occlusive coronary arteriosclerosis
###end article-title 35
###begin article-title 36
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Prevalence of ectasia in human coronary arteries in patients in Northern Greece referred for coronary angiography
###end article-title 36
###begin article-title 37
Atherogenesis and inflammation
###end article-title 37
###begin article-title 38
Alterations in circulating intercellular adhesion molecule-1 and L- selectin: further evidence for chronic inflammation in ischemic heart disease
###end article-title 38
###begin article-title 39
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris
###end article-title 39
###begin article-title 40
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
###end article-title 40
###begin article-title 41
Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
###end article-title 41
###begin article-title 42
Plasma interleukin-6 levels are increased in coronary artery ectasia
###end article-title 42
###begin article-title 43
Coronary ectasia: prevalence, and clinical and angiographic characteristics
###end article-title 43
###begin article-title 44
###xml 33 38 <span type="species:ncbi:9606">woman</span>
Myocardial infarction in a young woman with isolated coronary arteritis
###end article-title 44
###begin article-title 45
Effectiveness of an antiplatelet agent for coronary artery ectasia associated with silent myocardial ischemia
###end article-title 45
###begin article-title 46
Altered coronary flow properties in diffuse coronary artery ectasia
###end article-title 46
###begin article-title 47
Inflammation: an important mechanism for different clinical entities of coronary artery diseases
###end article-title 47
###begin article-title 48
Silent myocardial ischemia may be related to inflammatory response
###end article-title 48
###begin article-title 49
Inflammation in variant angina: is there any evidence?
###end article-title 49
###begin article-title 50
Aortic aneurysms secrete interleukin-6 into the circulation
###end article-title 50
###begin article-title 51
Expression of monocyte and lymphocyte adhesion molecules is increased in isolated coronary artery ectasia
###end article-title 51
###begin article-title 52
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease
###end article-title 52
###begin article-title 53
Plasma soluble adhesion molecule levels in coronary artery ectasia
###end article-title 53
###begin article-title 54
Coronary artery ectasia: is it a destructive inflammatory lesion of the vascular wall?
###end article-title 54
###begin p 55
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Clinical and coronary angiographic characteristics of patients with isolated coronary artery ectasia and controls.
###end p 55
###begin p 56
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</sup>
CAE: coronary artery ectasia; LAD: left anterior descending artery; LCx: left circumflex artery; RCA: right coronary artery; (a)Chi square.
###end p 56
###begin p 57
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
TNF-alpha and IL-6 levels in the patients with CAE and control group.
###end p 57
###begin p 58
###xml 34 39 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
CAE: coronary artery ectasia, TNF-alpha tumor necrosis factor-alpha, IL-6; and interleukin-6.
###end p 58

